Adrenal Cortex Neoplasms clinical trials
The registry lists 20 studies for Adrenal Cortex Neoplasms across more than 10 countries. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-04.
Keep track of what changes. Save the Adrenal Cortex Neoplasms studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWho runs them
National Cancer Institute (NCI) (5) · Children's Oncology Group (2) · St. Jude Children's Research Hospital (2) · Istanbul University (1) · Corcept Therapeutics (1) · Emory University (1) · Fundación de investigación HM (1) · National and Kapodistrian University of Athens (1)
What is being tested here
Drugs under test in Adrenal Cortex Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 8 Adrenal Cortex Neoplasms studies recruiting now, 3 (38%) set no upper age limit and 3 (38%) stop at 75 or younger. 4 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (50%) | 4 (50%) |
| 18 | 8 (100%) | 8 (100%) |
| 30 | 5 (63%) | 5 (63%) |
| 40 | 5 (63%) | 5 (63%) |
| 50 | 5 (63%) | 5 (63%) |
| 65 | 5 (63%) | 5 (63%) |
| 75 | 5 (63%) | 5 (63%) |
| 85 | 4 (50%) | 4 (50%) |
Across all 20 studies, recruiting or not: 30% stop at 75 or younger and 25% at 65; 40% take children; 0% are for women only and 0% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 6, 2026.
Newly registered1
- Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.Oct 28, 2026NCT07901582
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 11 country
- Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.RecruitingNCT07901582Not applicable1 country
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaRecruitingNCT05286814Phase 21 country
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/21 country
- International Pediatric Adrenocortical Tumor RegistryRecruitingNCT007004141 country
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 11 country
- Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerRecruitingNCT06006013Phase 21 country
- An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT070721431 country
- Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyRecruitingNCT060500571 country
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive, not recruitingNCT03604198Phase 210 countries
- Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian CohortCompletedNCT062794421 country
- Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticActive, not recruitingNCT02721732Phase 21 country
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical TumorCompletedNCT00304070Phase 34 countries
- Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)TerminatedNCT044470141 country
- Expression of Different Proliferation Biomarkers in Adreno-cortical TumorsStatus unknownNCT02747355
- Circulating Tumor DNA Exposure in Peripheral BloodStatus unknownNCT035173322 countries
- Studying Genes in Samples From Younger Patients With Adrenocortical TumorCompletedNCT01528956
- Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical CancerCompletedNCT01255137Phase 21 country
- Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical CancerCompletedNCT00071058Phase 21 country
- Cardiovascular Risk in Patients With Non-Functional Adrenal IncidentalomaCompletedNCT007683651 country